Invenomic Capital Management’s HireRight Holdings Corporation HRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-462,762
Closed -$6.22M 206
2023
Q4
$6.22M Sell
462,762
-350,699
-43% -$3.97M 0.28% 92
2023
Q3
$7.74M Sell
813,461
-2,749
-0.3% -$28.4K 0.33% 77
2023
Q2
$9.23M Sell
816,210
-218,297
-21% -$2.29M 0.47% 61
2023
Q1
$11M Buy
1,034,507
+23,140
+2% +$261K 0.62% 53
2022
Q4
$12M Buy
1,011,367
+97,348
+11% +$1.21M 0.81% 41
2022
Q3
$13.9M Sell
914,019
-30,962
-3% -$490K 1.2% 27
2022
Q2
$13.4M Buy
944,981
+270,400
+40% +$4.21M 0.95% 31
2022
Q1
$11.5M Buy
+674,581
New +$9.08M 1.23% 20

Other funds holding HRT

Invenomic Capital Management's HRT Position: Q1 2024 in Review

Invenomic Capital Management sold out of HireRight Holdings Corporation (HRT) in Q1 2024, closing a stake of 462,762 shares — an estimated $6.22M sold.

Invenomic Capital Management first reported a position in HRT in Q1 2022 and held it in 8 quarters. The position peaked at $13.9M in Q3 2022. 87 funds tracked by Wall St. Rank hold HRT as of Q1 2024.

  • Invenomic Capital Management reported no remaining HireRight Holdings Corporation position as of Q1 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 462,762 HireRight Holdings Corporation shares in Q1 2024, an estimated $6.22M.
  • Invenomic Capital Management first reported a position in HireRight Holdings Corporation in Q1 2022 and held it in 8 quarters.
  • Invenomic Capital Management's HireRight Holdings Corporation position peaked at $13.9M in Q3 2022.
  • 87 funds tracked by Wall St. Rank held HireRight Holdings Corporation as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.